University of Strathclyde Leads Groundbreaking Study on AI-Enhanced mRNA Vaccine Development
A groundbreaking research initiative spearheaded by the University of Strathclyde will investigate the transformative role of artificial intelligence (AI) and machine learning in the creation and production of mRNA-based vaccines and therapies. With support exceeding £440,000 from Innovate UK, this endeavor aims to enhance the timelines associated with genomic medicine, concentrating on genetic research for […]
Mount Sinai Researchers Unveil Breakthrough in Beta Cell Regeneration for Diabetes Treatment
Researchers at the Icahn School of Medicine at Mount Sinai have made a significant discovery in the search for scalable treatments for diabetes, identifying novel mechanisms by which the drug harmine, known for its beta cell regenerative properties, may convert pancreatic alpha cells into insulin-producing beta cells. These findings, published in Cell Reports Medicine, offer […]
Russia Unveils mRNA Cancer Vaccine to Revolutionize Treatment
Russia has recently declared it has found a cure for cancer in the form of vaccine that targets cancer patients. Planned to be ready for the mass production in early 2025, the vaccine will be fully paid from the state’s budget and free for the Russian people based on official media outlets. This bespoke approach […]
Lupin Launches Bumetanide Injection USP in the U.S. Market
Lupin Limited, a global leader in pharmaceuticals, has revealed the introduction of Bumetanide Injection USP in the U.S. market after receiving approval from the U.S. Food and Drug Administration (FDA). The injection is offered in Single-Dose Vials containing 1 mg/4 mL (0.25 mg/mL) and Multiple-Dose Vials of 2.5 mg/10 mL (0.25 mg/mL), serving as the […]
BDMS Holds Conference on Patient-Centered Care and Value-Based Healthcare
Bangkok Dusit Medical Services Public Company Limited (BDMS) recently conducted the BDMS Academic Annual Meeting 2024 from November 18 to 22 at the BDMS Connect Center in Bangkok, concentrating on the fusion of patient-centered care with the global movement towards Value-Based Healthcare. The conference, designed to encourage the sharing of medical knowledge, featured a keynote […]
Neuralink Receives Approval for First Clinical Trial in Canada
Elon Musk’s brain-chip company, Neuralink, said Wednesday that it has been given permission to launch its first clinical trial in Canada. A technology designed to enable people with paralysis to operate digital devices with just their thoughts will be tested during the experiment. Assessing the implant’s safety and early functionality will be the main goal […]
Report Highlights £268 Billion Annual Cost of Unhealthy Eating in the UK
Unhealthy eating practices have a huge financial impact on the UK, with a recent research from the Food, Farming and Countryside Commission (FFCC) indicating that the yearly cost is an astounding £268 billion. This amount, which is more than double the NHS’s annual budget, highlights the serious effects that unhealthy eating habits are having on […]
Telehealth Companies Allowed to Prescribe Controlled Medications Through 2025
A significant extension was granted to telehealth providers, enabling them to continue prescribing banned substances through 2025. This action is part of a continuous effort to improve access to healthcare, particularly for individuals who may not be able to travel to conventional medical facilities. Concerns about abuse and dependence have led to strict regulation of […]
Global Day of Action for Cervical Cancer Elimination: A United Effort
The famous Christ the Redeemer statue, which is shining in teal and represents a global commitment to the eradication of cervical cancer, greets world leaders arriving in Rio de Janeiro for the G20 Summit. The World Health Organization’s (WHO) “Day of Action for Cervical Cancer Elimination,” which is observed worldwide through awareness campaigns, immunization drives, […]
Zydus Lifesciences Secures WHO Prequalification for ZyVac TCV, Opening Doors to UN Procurement
Zydus Lifesciences Limited has declared the latest development as in-principle acceptability of the Vaccine has been granted by the WHO for its typhoid conjugate ZyVac TCV. This puts ZyVac TCV in a position to benefit from funds that are available and accessible by United Nations (UN) allowing for more expansive access to this potent tool […]